CVS Health intends to split off its pharmacies into a new company, while keeping together its businesses in insurance and pharmacy benefits, in a breakup planned for 2028. The move would dismantle the vertically integrated healthcare conglomerate it created in 2018 through its acquisition of Aetna for $78 billion. This decision marks a significant change in the company's strategy, as it seeks to separate its different business segments.
CVS Health plans to split into two separate public companies by the first half of 2028, reversing its $78 billion acquisition of Aetna. The company's shares have been affected by this announcement, with a notable decline in value.
As part of this restructuring, CVS will pursue cost cuts, aiming to reduce expenses and improve efficiency. The impact of this decision on the company's shares has been significant, with a substantial decrease in value following the announcement.
Evidence lens
2 cited sources are linked to this briefing.